Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pio Pharm Denmark ApS
APS
Active
CVR 43917951
Unovej 1
Manufacture of other food products n.e.c. · NACE 1089
Est. 2023
16 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -9,4M
+27% vs 2023
EBITDA margin
153.9%
-68% vs 2023
Equity ratio
-15.6%
Financial strength
Net profit 2024
DKK -16,3M
-88% vs 2023
EBITDA — year on year
DKK millions
0M
-3M
-6M
-8M
-11M
-9M
2023
-14M
-56%
2024
Key figures
Annual report 2024
Revenue
DKK -9,4M
+27%
EBITDA
DKK -14,5M
-68%
Net profit
DKK -16,3M
-88%
Total assets
DKK 46,4M
+328%
Equity
DKK -7,3M
-4418%
Employees
16
—
Company information
Legal name
Pio Pharm Denmark ApS
CVR number
43917951
Legal form
Anpartsselskab
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
10. marts 2023
Share capital
DKK 17.666.666
Employees
16 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at fremstille fødevarer samt hermed beslægtet virksomhed.
Contact
Address
Unovej 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of other food products n.e.c.
Companies in Halsnæs
All Denmark companies
Revenue
DKK millions
0M
-2M
-4M
-6M
-8M
-7M
2023
-9M
2024
EBITDA
DKK millions
0M
-3M
-5M
-8M
-10M
-9M
2023
-14M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
-7.407
-9.411
Staff expenses
-1.234
-5.070
EBITDA
-8.641
-14.481
Depreciation & amort.
-6
-1.036
EBIT
-8.647
-15.517
Net financials
-19
-735
Profit before tax
-8.665
-16.253
Tax
-0
-0
Net profit
-8.665
-16.253
Balance sheet
DKK thousands
Item
2023
2024
Total assets
10.833
46.359
Equity
168
-7.251
Long-term debt
0
0
Short-term debt
10.665
53.610
Total debt
10.665
53.610
Financial ratios
5-year trend
EBITDA margin
-1448098600.0%
This company
15.8%
Market median
-9165181113% vs market
2023
2024
Equity ratio
-15.6%
This company
38.2%
Market median
-141% vs market
2023
2024
Return on equity
-1625266800.0%
This company
18.4%
Market median
-8832971839% vs market
2023
2024
Net profit margin
-1625266800.0%
This company
8.1%
Market median
-20065022322% vs market
2023
2024
Asset turnover
-0.20×
This company
1.12×
Market median
-118% vs market
2023
2024
Debt / equity
7.39×
This company
0.62×
Market median
-1092% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-03-10 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LN
Lasse Nagell
Management
Management
2023
—
—
HP
Hyonam Park
Management
Management
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
PIOPHARM CO., LTD
Individual
50.0%
50.0%
2023
DENPS ApS
Company
33.3%
33.3%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
DENPS ApS
Pio Pharm Denmark ApS
(this company)
Board network connections
Board members of Pio Pharm Denmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Lasse Nagell
Management
0 companies
Hyonam Park
Management
0 companies